The results verify conclusions drawn by Bagli et al. [one], who executed a study that bundled ten patients diagnosed with CRAO who received HBOT. In addition to obtaining 20 classes of HBOT, oral acetazolamide and topical beta-blockers were administered towards the patients in the earliest doable time.It is far from identified if OPDIVO is safe and